Loading...

NRVG

NGN

NERVGEN PHARMA CORP

(NGEN)

2026 6-K

6-K Filing Summary

15 May '26

CFO Appointment

27 Apr '26

Delisting Announcement

13 Mar '26

Management Change

13 Feb '26

CEO Appointment

10 Feb '26

External Links:

SEC

NervGen Pharma Corp. announced on February 9, 2026, the appointment of Dr. Adam Rogers as CEO, with an annual salary of $350,000 and stock options for 717,891 shares at prices of $5.06 and $5.57.

AI Assistant

NERVGEN PHARMA CORP

2026

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.